graph Evidence gap map comparisons
abemaciclib based treatment
abemaciclib plus aromatase inhibitor abemaciclib plus endocrine therapy abemaciclib plus fulvestrant
Comparator:  vs endocrine therapy;   vs aromatase inhibitor;   vs fulvestrant; 
Risk of bias:  low;   some concerns;   high;  NA;